Pharmaceutical Technology
December 02, 2015
Peer-Reviewed Research
39
12
Microorganism lethality requirements for process validation must always be balanced with the need to protect product integrity and patient safety.
December 02, 2015
Features
39
12
All openings and potential apertures for air penetration must be considered when designing a cleanroom so that the HVAC system can maintain the desired negative or positive pressure.
December 02, 2015
Troubleshooting
39
12
Analytical methods and functional assays are used to compare molecules and relate characteristics to quality attributes.
December 02, 2015
Regulatory Watch
39
12
FDA confirmed quality focus while Congress moved to bolster biomedical innovation.
December 02, 2015
Features
39
12
Investing in worker training is crucial to the success of a company. This article reviews the benefits of a robust training program in pharmaceutical bulk manufacturing.
December 02, 2015
Formulation
39
12
The advantages of fixed-dose combinations are well recognized but their formulation and manufacture can be a challenge, Stefania Barzanti from IMA Active explains why.
December 02, 2015
Regulatory Watch
39
12
Finalizing GMP requirements and quality standards for the development, manufacture, and clinical testing of ATMPs in the EU is proving to be a complex task.
December 02, 2015
From The Editor
39
12
Employers have work to do to improve job satisfaction and retain qualified workers.
December 02, 2015
API Synthesis and Manufacturing
39
12
A strong API market is expected in 2016 despite fewer new drug approvals.
December 02, 2015
Cover Story
39
12
Bio/pharma employee dissatisfaction with pay and progress may direct some to new career pathways.
December 02, 2015
Outsourcing Outlook
39
12
CMO industry consolidation may be frustrated by a dearth of attractive assets.
December 02, 2015
Global Market Report
39
12
The author provides an overview of the key aspects of the current Canadian pharmaceutical market.
December 02, 2015
Features
39
12
The CEO of a US-based biosimilar manufacturer explains the legal and intellectual property issues of bringing a biosimilar to market in the United States.
December 02, 2015
Ask the Expert
39
12
Susan Schniepp, distinguished fellow, and Andrew Harrison, chief regulatory affairs officer and general counsel, both of Regulatory Compliance Associates, discuss how to write standard operating procedures that hold up to audits.
December 02, 2015
Features
39
12
Quality by design, in-vitro release testing, and modern analytical methods are improving understanding and control of these complex formulations.
December 02, 2015
Cover Story
39
12
Intellectual challenge, job security, and opportunity for advancement contribute to employee happiness, but the ultimate prize may be a satisfactory salary for bio/pharma employees in Europe.